Especialitat
Retina i Vitri
Títol complet
A Phase III Double-Blind, Parallel Group, Multicenter Study to Compare the Efficacy and Safety of Xlucane versus Lucentis in Patients with Neovascular Age-Related Macular Degeneration
Promotor
Xbrane Biopharma
Data d'inici
Juny 2019
Investigadors
Principal: Dra Anniken Burés
Co-Investigadors: Dr. Rafael Navarro, Dr. Borja Corcóstegui, Dr. Carlos Mateo, Dra. Cecilia Salinas
